Compare NNNN & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | LOCO |
|---|---|---|
| Founded | 2021 | 1980 |
| Country | Germany | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.8M | 411.3M |
| IPO Year | N/A | 2014 |
| Metric | NNNN | LOCO |
|---|---|---|
| Price | $9.25 | $16.40 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.17 |
| AVG Volume (30 Days) | 33.6K | ★ 174.3K |
| Earning Date | 04-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.65 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $401,701,000.00 |
| Revenue This Year | N/A | $3.60 |
| Revenue Next Year | N/A | $3.98 |
| P/E Ratio | $446.57 | ★ $61.00 |
| Revenue Growth | N/A | ★ 5.68 |
| 52 Week Low | $8.30 | $8.99 |
| 52 Week High | $54.90 | $17.40 |
| Indicator | NNNN | LOCO |
|---|---|---|
| Relative Strength Index (RSI) | 37.56 | 53.98 |
| Support Level | $8.30 | $15.84 |
| Resistance Level | $29.98 | $17.21 |
| Average True Range (ATR) | 1.31 | 0.38 |
| MACD | 0.58 | -0.05 |
| Stochastic Oscillator | 33.89 | 65.38 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.